BioSpace News Archive

The global ECG Management Systems Market is likely to be driven by the rising frequency of cardiac arrhythmia and rising demand for ambulatory monitoring equipment.

The medical condition when one cannot voluntary control one’s ability to urinate or defecate, then it is known as incontinence.

Core One Labs Inc. is pleased to announce that its wholly owned subsidiary Akome Biotech Ltd. (“Akome”) has signed a consulting agreement with the Universitat de Barcelona (the “ University of Barcelona ” or the “ University ”), Faculty of Pharmacy and Food Sciences, Laboratory of Medicinal Chemistry, of Barcelona, Spain.

Royal Philips, a global leader in health technology, announced the introduction of the industry’s first full-service, at-home, 12-lead electrocardiogram solution for use in decentralized clinical trials.

OKYO Pharma Limited a biopharmaceutical company developing next-generation therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain announces its interim results for the six months ended 30 September 2021.

MediciNova, Inc. and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that it has received a Notice of Intention to Grant from the European Patent Office for a pending patent application which covers MN-001 (tipelukast) and MN-002 (a major metabolite of MN-001) for hepatic ballooning.

Avivagen Inc announces a CEO update to shareholders.

Ascletis Pharma Inc. announces that following the consultation with China National Medical Products Administration, the Investigational New Drug application of its second fatty acid synthase inhibitor ASC60 for advanced solid tumors has been accepted by China NMPA.

NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage, biopharmaceutical company, has received a first safety report from a Southwestern hospital where physicians have administered ZYESAMI® (Aviptadil) to patients with COVID-19 respiratory failure.

Recro Pharma, Inc. today announced that it has been awarded a new formulation development and cGMP manufacturing contract from a key department of the United States government.